Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Buy
66
TGRP Quote, Financials, Valuation and Earnings
Last price:
$0.0500
Seasonality move
:
16.62%
Day range:
$0.0498 - $0.0498
52-week range:
$0.0140 - $0.0900
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.04x
P/B ratio:
188.37x
Volume:
100
Avg. volume:
7.1K
1-year change:
105.79%
Market cap:
$8.7M
Revenue:
$3.8M
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, TRON Pharmaceuticals, Inc. has -- downside to fair value with a price target of -- per share.
TGRP vs. S&P 500
-
Over the past 5 trading days, TRON Pharmaceuticals, Inc. has overperformed the S&P 500 by 34.18% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
TRON Pharmaceuticals, Inc. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
TRON Pharmaceuticals, Inc. revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter TRON Pharmaceuticals, Inc. reported revenues of --.
Earnings Growth
-
TRON Pharmaceuticals, Inc. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter TRON Pharmaceuticals, Inc. reported earnings per share of --.
Enterprise value:
13.6M
EV / Invested capital:
--
Price / LTM sales:
2.04x
EV / EBIT:
89.29x
EV / Revenue:
3.03x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-9.54x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
29.15x
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | $4.5M | -- | $1.4M | |
| Gross Profit | -- | -- | $1.4M | -- | $699.1K | |
| Operating Income | -- | -- | $151.8K | -- | $465.5K | |
| EBITDA | -- | -- | $465.2K | -- | $541.1K | |
| Diluted EPS | -- | -- | -$0.00 | -- | $0.00 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.2K | -- | -- | -- | $991.3K | |
| Total Assets | $977.9K | $965.9K | -- | -- | $5.5M | |
| Current Liabilities | $141K | $167.7K | -- | -- | $1.6M | |
| Total Liabilities | $1.1M | $1.1M | -- | -- | $4.3M | |
| Total Equity | -$81.1K | -$117.7K | -- | -- | $1.2M | |
| Total Debt | $42.9K | $46.3K | -- | -- | $2.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | $33K | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | $176.9K | |
| Free Cash Flow | -- | -- | -- | -- | $33K | |
TGRP
Sector
Market Cap
$8.7M
--
Price % of 52-Week High
55.33%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
105.79%
--
Beta (5-Year)
-2.227
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.0374
200-day SMA
Buy
Level
$0.0397
Bollinger Bands (100)
Buy
Level
0.0219 - 0.0619
Chaikin Money Flow
Buy
Level
332.2K
20-day SMA
Buy
Level
$0.0392
Relative Strength Index (RSI14)
Buy
Level
59.7409
ADX Line
Buy
Level
31.2838
Williams %R
Sell
Level
0
50-day SMA
Sell
Level
$0.0504
MACD (12, 26)
Sell
Level
-0.0027
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Sell
Level
-329.3K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.0207)
Sell
CA Score
(Annual)
Level (-2.6376)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (5.2819)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
TRON Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development of oral, topical, and injectable products for cancer, central nervous system disorders, and infectious diseases. The company was founded on October 20, 2015 and is headquartered in Alachua, FL.
Stock Forecast FAQ
In the current month, TGRP has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TGRP average analyst price target in the past 3 months is --.
-
Where Will TRON Pharmaceuticals, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that TRON Pharmaceuticals, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About TRON Pharmaceuticals, Inc.?
Analysts are divided on their view about TRON Pharmaceuticals, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that TRON Pharmaceuticals, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is TRON Pharmaceuticals, Inc.'s Price Target?
The price target for TRON Pharmaceuticals, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is TGRP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for TRON Pharmaceuticals, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of TGRP?
You can purchase shares of TRON Pharmaceuticals, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase TRON Pharmaceuticals, Inc. shares.
-
What Is The TRON Pharmaceuticals, Inc. Share Price Today?
TRON Pharmaceuticals, Inc. was last trading at $0.0500 per share. This represents the most recent stock quote for TRON Pharmaceuticals, Inc.. Yesterday, TRON Pharmaceuticals, Inc. closed at $0.0498 per share.
-
How To Buy TRON Pharmaceuticals, Inc. Stock Online?
In order to purchase TRON Pharmaceuticals, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get TGRP Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TGRP
Sector
P/E ratio
--
--
PEG ratio
--
--
P/B ratio
188.37x
--
Price / LTM sales
2.04x
--
Growth Metrics
TGRP
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
20.8%
--
Earnings forecast
--
--
Profitability
TGRP
Sector
Profitability FY 2024
$1M
--
Return on invested capital
--
--
Return on assets
--
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Dec
8
Next Earnings Date
Dec
8
Estimated Next Earnings Date
Mar
9
Balance Sheet
TGRP
Sector
Total cash
--
--
Short term investments
--
--
Total assets
$5M
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
50
TGL alert for Dec 8
Treasure Global, Inc. [TGL] is up 29.72% over the past day.
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 46.38% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 9.68% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
